| Full Term | |
| AEH | Atypical Endometrial Hyperplasia |
| EIN | Endometrial Intraepithelial Neoplasia |
| EAH | Endometrial Atypical Hyperplasia |
| EEC | Endometrioid Endometrial Cancer |
| EC | Endometrial Cancer |
| EAC | Endometrial Adenocarcinoma |
| LNG-IUS | Levonorgestrel-Releasing Intrauterine System |
| MA | Megestrol Acetate |
| MPA | Medroxyprogesterone Acetate |
| CR | Complete Response |
| PCOS | Polycystic Ovary Syndrome |
| PMOS | Polyendocrine Metabolic Ovarian Syndrome |
| IVF | In Vitro Fertilization |
| ART | Assisted Reproductive Technology |
| BMI | Body Mass Index |
| AMPK | AMP-Activated Protein Kinase |
| mTOR | Mammalian Target of Rapamycin |
| mTORC1 | Mammalian Target of Rapamycin Complex 1 |
| PI3K | Phosphatidylinositol 3-Kinase |
| AKT | Protein Kinase B |
| IGF-1 | Insulin-Like Growth Factor 1 |
| IGF-1R | Insulin-Like Growth Factor 1 Receptor |
| ERα | Estrogen Receptor Alpha |
| S6K1 | Ribosomal Protein S6 Kinase Beta-1 |
| EIF4E | Eukaryotic Translation Initiation Factor 4E |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RCT | Randomized Controlled Trial (mentioned through study design context) |
| NR | Not Reported |